Jia Zhou

75PUBLICATIONS
115CO-AUTHORS
Innate immunityProteins and peptidesNeurology and neuromuscular diseasesToxicology (incl. clinical toxicology)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (75)

|Jul 15, 2026
Butyrate epigenetically licenses sustained epithelial-T cell crosstalk for intestinal immune tolerance.

|Jun 18, 2026
Discovery of Small Molecule Ligands Targeting Orphan G Protein-Coupled Receptors GPR3, GPR6, and GPR12.

|Apr 21, 2026
Drug Discovery of Antiviral Inhibitors Targeting Dengue Virus NS4B Protein.

|Apr 09, 2026
CVN-424: An Advanced GPR6 Inverse Agonist in Phase III Clinical Trials for Parkinson's Disease.

Xiaochen Tian, Saghir Ali, John A Allen

|Mar 12, 2026
Efficient In Vivo Pharmacological Inhibition of ΔFOSB, an AP-1 Transcription Factor, in the Brain.

Sean McNeme, Anil Kumar, Yun Young Yim

|Feb 26, 2026
Prevalence of Halogens in 2025 FDA-Approved Drugs: Highlight on Suzetrigine, the First Nonopioid Painkiller in Decades.

Saghir Ali, Cun Zhang, Jia Zhou

Pageof 13

Frequent Collaborators

11 joint publications

Eric A Wold

8 joint publications

Zonghui Ma

8 joint publications

Kathryn A Cunningham

6 joint publications

Zhiqing Liu